Hermo Pharma Overview

  • Founded
  • 2008
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 1
Employees
  • Latest Deal Type
  • M&A

Hermo Pharma General Information

Description

Operator of a drug discovery and development company. The company focuses on the development of disease restoring medicines for neurological disorders. It develops drugs therapy for the treatment of Amblyopia, Parkinson's and Alzheimer's disease.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Drug Discovery
Acquirer
Primary Office
  • Viikinkaari 4
  • 00790 Helsinki
  • Finland
+358 09 0000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Hermo Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 12-May-2014 00.000 Completed Generating Revenue
7. Early Stage VC 13-Jun-2013 00.000 Completed Startup
6. Grant 07-Dec-2012 00000 00.000 Completed Startup
5. Early Stage VC (Series A) 24-Apr-2012 00.000 00.000 Completed Clinical Trials - Phase 2
4. Early Stage VC 01-Jul-2011 Completed Startup
3. Early Stage VC 01-Apr-2010 Completed Startup
2. Grant 12-Feb-2010 Completed Startup
1. Seed Round 16-Dec-2009 Completed Startup
To view Hermo Pharma’s complete valuation and funding history, request access »

Hermo Pharma Executive Team (7)

Name Title Board Seat Contact Info
Eero Castrén Ph.D Co-Founder & Member of Scientific Advisory Board
Heikki Rauvala Ph.D Co-Founder & Member of Scientific Advisory Board
Mart Saarma Ph.D Co-Founder, Board Member & Member of Scientific Advisory Board
You’re viewing 3 of 7 executive team members. Get the full list »

Hermo Pharma Board Members (8)

Name Representing Role Since
Ari-Pekka Laitsaari Self Chairman 000 0000
Eero Castrén Ph.D Hermo Pharma Co-Founder & Member of Scientific Advisory Board 000 0000
Heikki Rauvala Ph.D Hermo Pharma Co-Founder & Member of Scientific Advisory Board 000 0000
Jyrki Mattila Self Board Member 000 0000
Mart Saarma Ph.D Self Co-Founder, Board Member & Member of Scientific Advisory Board 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Hermo Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hermo Pharma Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Finnvera Venture Capital Minority 000 0000 000000 0
Michael J. Fox Foundation Limited Partner Minority 000 0000 000000 0
Tekes Not-For-Profit Venture Capital Minority 000 0000 000000 0
University of Helsinki Endowment Limited Partner Minority 000 0000 000000 0
To view Hermo Pharma’s complete investors history, request access »